Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Menopause
Biotech
Bayer to take menopause drug to regulators after 3rd ph. 3 win
Bayer's hot flash drug has struck phase 3 gold again, setting up the pharma to approach regulators about following Astellas’ Veozah to market.
James Waldron
Mar 19, 2024 7:17am
Biden asks Congress for $12B to fund women's health research
Mar 8, 2024 10:25am
Bayer hits hot flash phase 3 goals to stay on Astellas’ heels
Jan 8, 2024 10:16am
Cash-strapped Acer sees menopause drug flunk phase 2 trial
Mar 17, 2023 10:11am
FDA thwarts Astellas' accelerated approval ambition in menopause
Feb 20, 2023 7:20am
Astellas' menopause therapy accepted for FDA review
Aug 18, 2022 8:50am